Cargando…
Estimating the Prevalence of a True Oligometastatic Disease
Autores principales: | Szturz, Petr, Bonomo, Pierluigi, Vermorken, Jan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818742/ https://www.ncbi.nlm.nih.gov/pubmed/36612215 http://dx.doi.org/10.3390/cancers15010214 |
Ejemplares similares
-
Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond
por: Szturz, Petr, et al.
Publicado: (2021) -
Oligometastatic Disease Management: Finding the Sweet Spot
por: Szturz, Petr, et al.
Publicado: (2020) -
Steering decision making by terminology: oligometastatic versus argometastatic
por: Szturz, Petr, et al.
Publicado: (2022) -
Translating KEYNOTE-048 into practice recommendations for head and neck cancer
por: Szturz, Petr, et al.
Publicado: (2020) -
Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016)